Castilla-La Mancha leads, according to data from the Ministry of Health, the use of biosimilars in hospitals of the National Health System. The keys, according to the regional administration itself, have been information and training for professionals and patients, the involvement of services and centers and support for the analysis of the use of biosimilars. In addition, looking forward, the region plans to further boost the use of these medicines, while ensuring the availability of all products through a biosimilar framework agreement.

READ MORE